Challenges and importance of formulae equating catecholamine and non-catecholamine vasoconstrictor dosages

J Crit Care. 2021 Apr:62:243-245. doi: 10.1016/j.jcrc.2020.12.020. Epub 2020 Dec 25.

Authors

Patrick M Wieruszewski¹, Ashish K Khanna²

Affiliations

¹ Department of Pharmacy, Mayo Clinic, Rochester, MN, USA; Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Laboratory, Mayo Clinic, Rochester, MN, USA. Electronic address: wieruszewski.patrick@mayo.edu.
² Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest School of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA; Outcomes Research Consortium, Cleveland, OH, USA.

PMID: 33453681
DOI: 10.1016/j.jcrc.2020.12.020

No abstract available

MeSH terms

Catecholamines
Humans
Shock, Septic* / drug therapy
Sympathomimetics
Vasoconstrictor Agents* / adverse effects

Substances

Catecholamines
Sympathomimetics
Vasoconstrictor Agents